Compare KMDA & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMDA | WEYS |
|---|---|---|
| Founded | 1990 | 1906 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.3M | 433.3M |
| IPO Year | 2013 | 1995 |
| Metric | KMDA | WEYS |
|---|---|---|
| Price | $8.73 | $46.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 140.7K | 18.8K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | 3.08% | ★ 3.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.04 |
| Revenue | N/A | ★ $276,169,000.00 |
| Revenue This Year | $13.94 | N/A |
| Revenue Next Year | $9.84 | N/A |
| P/E Ratio | $24.59 | ★ $22.98 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.50 | $27.25 |
| 52 Week High | $9.35 | $48.68 |
| Indicator | KMDA | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 62.94 | N/A |
| Support Level | $7.91 | N/A |
| Resistance Level | $8.88 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 85.85 | 0.00 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.